Variant Location Is a Novel Risk Factor for Individuals With Arrhythmogenic Cardiomyopathy Due to a Desmoplakin (DSP) Truncating Variant.
Hoorntje ET., Burns C., Marsili L., Corden B., Parikh VN., Te Meerman GJ., Gray B., Adiyaman A., Bagnall RD., Barge-Schaapveld DQCM., van den Berg MP., Bootsma M., Bosman LP., Correnti G., Duflou J., Eppinga RN., Fatkin D., Fietz M., Haan E., Jongbloed JDH., Hauer AD., Lam L., van Lint FHM., Lota A., Marcelis C., McCarthy HJ., van Mil AM., Oldenburg RA., Pachter N., Planken RN., Reuter C., Semsarian C., van der Smagt JJ., Thompson T., Vohra J., Volders PGA., van Waning JI., Whiffin N., van den Wijngaard A., Amin AS., Wilde AAM., van Woerden G., Yeates L., Zentner D., Ashley EA., Wheeler MT., Ware JS., van Tintelen JP., Ingles J.
BackgroundTruncating variants in desmoplakin (DSPtv) are an important cause of arrhythmogenic cardiomyopathy; however the genetic architecture and genotype-specific risk factors are incompletely understood. We evaluated phenotype, risk factors for ventricular arrhythmias, and underlying genetics of DSPtv cardiomyopathy.MethodsIndividuals with DSPtv and any cardiac phenotype, and their gene-positive family members were included from multiple international centers. Clinical data and family history information were collected. Event-free survival from ventricular arrhythmia was assessed. Variant location was compared between cases and controls, and literature review of reported DSPtv performed.ResultsThere were 98 probands and 72 family members (mean age at diagnosis 43±8 years, 59% women) with a DSPtv, of which 146 were considered clinically affected. Ventricular arrhythmia (sudden cardiac arrest, sustained ventricular tachycardia, appropriate implantable cardioverter defibrillator therapy) occurred in 56 (33%) individuals. DSPtv location and proband status were independent risk factors for ventricular arrhythmia. Further, gene region was important with variants in cases (cohort n=98; Clinvar n=167) more likely to occur in the regions, resulting in nonsense mediated decay of both major DSP isoforms, compared with n=124 gnomAD control variants (148 [83.6%] versus 29 [16.4%]; P<0.0001).ConclusionsIn the largest series of individuals with DSPtv, we demonstrate that variant location is a novel risk factor for ventricular arrhythmia, can inform variant interpretation, and provide critical insights to allow for precision-based clinical management.